Yahoo
NasdaqCM - Nasdaq Real Time Price USD

CapsoVision, Inc. (CV)

6.32 0.00 (0.00%)
As of 9:30:02 AM EST. Market Open.
Trade CV on Coinbase
Chart Range Bar
Loading chart for CV
  • Previous Close 6.32
  • Open 6.22
  • Bid 4.58 x 200
  • Ask 7.97 x 200
  • Day's Range 6.32 - 6.32
  • 52 Week Range 4.50 - 15.37
  • Volume 119,883
  • Avg. Volume 168,751
  • Market Cap (intraday) 336.289M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.45
  • Earnings Date Nov 12, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 9.50
  • Motley Fool Rating Bearish

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

capsovision.com

99

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CV
40.88%
S&P 500 (^GSPC)
7.76%

1-Year Return

CV
31.67%
S&P 500 (^GSPC)
9.77%

3-Year Return

CV
26.40%
S&P 500 (^GSPC)
68.96%

5-Year Return

CV
26.40%
S&P 500 (^GSPC)
57.04%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 2.79M
Earnings -7.03M
Profit Margin -251.90%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-6M
-4M
-2M
0
2M
4M
-240.0%
-220.0%
-200.0%
-180.0%
-160.0%
-140.0%

Analyst Insights

View More

Analyst Price Targets

9.00
9.50 Average
6.32 Current
10.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 3/27/2026
Analyst Benchmark
Rating Action Maintains
Rating Speculative Buy
Price Action Lowers
Price Target 14 -> 10

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -214.74%

  • Return on Assets (ttm)

    -132.47%

  • Return on Equity (ttm)

    -335.06%

  • Revenue (ttm)

    13.89M

  • Net Income Avi to Common (ttm)

    -29.83M

  • Diluted EPS (ttm)

    -0.45

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.08M

  • Total Debt/Equity (mrq)

    5.22%

  • Levered Free Cash Flow (ttm)

    -16.28M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: